Switzerland to donate up to 15 million vaccines to COVAX
Switzerland is to donate a maximum of 15 million shots of coronavirus vaccine in the first half of this year to the COVAX initiative for equitable vaccine distribution.
With a total of 34 million vaccines available for 2022, the Swiss population of 8.7 million is more than covered – even in the case of another booster campaign, the government said on Wednesday.
As such, it will make a maximum of 15 million shots available to the COVAX initiative, the multilateral project to funnel vaccines from richer to poorer countries in an effort to reduce inequalities.
“From the outset, as part of global efforts to manage the pandemic, Switzerland has been working to ensure that as many people as possible all over the world get access to safe and effective Covid-19 vaccines,” the government wroteExternal link.
It pointed to two previous gestures: a donation of four million AstraZeneca doses in June 2021 (after the Swiss health regulator did not approve it for use here), and the deferral of a purchase of a million doses of Moderna vaccine last December to allow COVAX to benefit from the freed-up production capacity.
While the vaccination rate in Switzerland stands at over 70%, many other countries – especially in Africa – have not managed to progress beyond small percentages of the population, as data from ReutersExternal link shows.
More
More
In the vaccine race, can COVAX help poorer countries catch up?
This content was published on
COVAX expects to start rolling out Covid-19 vaccines to poorer countries at the end of February. Can it really help them catch up?
The government also said on Wednesday it was planning to centralise the purchase of new drugs aimed at protecting those particularly vulnerable to Covid-19, for example immune-supressed people with underlying conditions.
Without naming specific medicines – simply saying they will “come up for approval in 2022” – the government said it would agree purchase guarantees with manufacturers so that they can be quickly made available to the people affected when available.
Last week, after the announcement that almost all public health measures to stem the spread of Covid-19 were ending in Switzerland, some groups of at-risk people voiced concern about their ongoing vulnerability to the disease.
The government added that such drugs for “passive immunisation” would be purchased in the future specifically for such vulnerable groups, rather than as an alternative to vaccination for the general public.
This content was published on
Nemo brought the Eurovision Song Contest to Switzerland with a victory on Saturday evening in Malmö, Sweden. It is Switzerland's third victory in the history of the music contest.
Switzerland abstains from vote on Palestinian bid for full UN membership
This content was published on
On Friday, Switzerland abstained from the vote at the General Assembly on granting the Palestinians new rights at the United Nations (UN).
Protein in abdominal fat could help shape obesity treatment
This content was published on
The study analysed fat cells from different locations in the body, and found that those in the abdomen have unique properties.
North African asylum claims fall after rapid Swiss processing
This content was published on
The accelerated procedure, now out of its test phase, has resulted in a significant drop in applications from North African countries.
This content was published on
The artist's song "The Code" focuses on their journey as a nonbinary individual. It is one of the favourites to win this year's contest.
This content was published on
The Swiss government has set out plans to contain the impact of a potential new wave of Covid-19 infections later this year.
Why Swiss participation in WHO’s Covid-19 vaccine plan matters
This content was published on
As the second coronavirus wave makes finding vaccines even more urgent, we look at Swiss participation in the WHO's vaccine pool.
Swiss should intensify cooperation with Covax, say experts
This content was published on
Rich countries should donate their surplus Covid-19 vaccines to poorer countries immediately, says the president of the international federation of pharma manufacturers.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.